Phase I Dose-Escalation Study of a Monovalent Heat Shock Protein 70-Herpes Simplex Virus Type 2 (HSV-2) Peptide-Based Vaccine Designed To Prime or Boost CD8 T-Cell Responses in HSV-Naive and HSV-2-Infected Subjects

David M. Koelle, Amalia Magaret, Christopher L. McClurkan, Michael L. Remington, Terri Warren, Florentina Teofilovici and Anna Wald

Clinical and Vaccine Immunology 15 ( 5 ): 773 - 782 , 2008